Tertiary lymphoid structure‐related RNA indicator as metastasis risk factor in nasopharyngeal carcinoma

Documenti analoghi

• Pre‐existing CD95‐based Temra immunity in patients with recurrent/metastatic nasopharyngeal carcinoma predicts response and hyperprogression to dual PD‐L1 and TGFβ inhibition
  di: Ngar Woon Kam, et al.
  Pubblicazione: (2025)
• Front Cover Picture: Rapid (Deuterio)difluoromethylation of Heteroatoms Using R‐22 Gas: A Demonstration of Flow Chemistry in Suppressing Intrinsic Reaction Pathways (Adv. Synth. Catal. 21/2024)
  di: Hon Cheung Leung, et al.
  Pubblicazione: (2024)
• Tertiary lymphoid structures: Defining immune subtypes and enabling precision immunotherapy in nasopharyngeal carcinoma
  di: Fan Liu, et al.
  Pubblicazione: (2025)
• The Use of Single Pass Albumin Dialysis and Hemoadsorption in Management of Life‐Threatening Amlodipine Overdose
  di: Wun Fung Hui, et al.
  Pubblicazione: (2024)
• ROS Self‐Supply Nanoplatform Based on Fenton Catalyst for Chemodynamic and Immunotherapy: Reprogramming Cold Tumor Into Hot Tumor in Cancer Treatment
  di: Man Lung Lee, et al.
  Pubblicazione: (2026)